BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23868006)

  • 1. Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer.
    Chaput N; Svrcek M; Aupérin A; Locher C; Drusch F; Malka D; Taïeb J; Goéré D; Ducreux M; Boige V
    Br J Cancer; 2013 Aug; 109(4):1013-22. PubMed ID: 23868006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.
    Nakanishi H; Miyata Y; Mochizuki Y; Yasuda T; Nakamura Y; Araki K; Sagara Y; Matsuo T; Ohba K; Sakai H
    Hum Pathol; 2018 Sep; 79():102-108. PubMed ID: 29787818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
    Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
    Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
    Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
    Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.
    Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH
    Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
    Pentheroudakis G; Raptou G; Kotoula V; Wirtz RM; Vrettou E; Karavasilis V; Gourgioti G; Gakou C; Syrigos KN; Bournakis E; Rallis G; Varthalitis I; Galani E; Lazaridis G; Papaxoinis G; Pectasides D; Aravantinos G; Makatsoris T; Kalogeras KT; Fountzilas G
    PLoS One; 2015; 10(5):e0124612. PubMed ID: 25970543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.
    Silva-Figueroa A; Villalobos P; Williams MD; Bassett RL; Clarke CN; Lee JE; Busaidy NL; Perrier ND
    Surgery; 2018 Nov; 164(5):960-964. PubMed ID: 30033186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.
    Cavnar MJ; Turcotte S; Katz SC; Kuk D; Gönen M; Shia J; Allen PJ; Balachandran VP; D'Angelica MI; Kingham TP; Jarnagin WR; DeMatteo RP
    Ann Surg Oncol; 2017 Jul; 24(7):1835-1842. PubMed ID: 28213791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of CD204-overexpressing Macrophages Contributes to the Progression of Stage II and III Colorectal Cancer.
    Tada Y; Matsumi Y; Hara K; Miyauchi W; Sugesawa K; Uejima C; Tanio A; Kihara K; Yamamoto M; Takano S; Sakamoto T; Nakayama Y; Hasegawa T; Fujiwara Y
    Anticancer Res; 2021 Oct; 41(10):4857-4865. PubMed ID: 34593433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
    Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
    BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients.
    Aasebø K; Bruun J; Bergsland CH; Nunes L; Eide GE; Pfeiffer P; Dahl O; Glimelius B; Lothe RA; Sorbye H
    Br J Cancer; 2022 Jan; 126(1):48-56. PubMed ID: 34671130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma.
    Gao Q; Zhou J; Wang XY; Qiu SJ; Song K; Huang XW; Sun J; Shi YH; Li BZ; Xiao YS; Fan J
    Ann Surg Oncol; 2012 Feb; 19(2):455-66. PubMed ID: 21792513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
    Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
    Front Immunol; 2021; 12():724429. PubMed ID: 34512652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Low Densities of FoxP3
    Cavalleri T; Bianchi P; Basso G; Celesti G; Grizzi F; Bossi P; Greco L; Pitrone C; Valtorta E; Mauri G; Truini M; Dall'Olio FG; Brandi G; Sartore-Bianchi A; Ricciardiello L; Torri V; Rimassa L; Siena S; Mantovani A; Malesci A; Laghi L;
    Cancer Immunol Res; 2019 May; 7(5):751-758. PubMed ID: 30804005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.
    Kadota K; Yeh YC; Villena-Vargas J; Cherkassky L; Drill EN; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Chest; 2015 Sep; 148(3):711-721. PubMed ID: 25836013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.
    Fujiyoshi K; Väyrynen JP; Borowsky J; Papke DJ; Arima K; Haruki K; Kishikawa J; Akimoto N; Ugai T; Lau MC; Gu S; Shi S; Zhao M; Da Silva AFL; Twombly TS; Nan H; Meyerhardt JA; Song M; Zhang X; Wu K; Chan AT; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    EBioMedicine; 2020 Jul; 57():102860. PubMed ID: 32652320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.